6533b871fe1ef96bd12d188b

RESEARCH PRODUCT

Follow-up results of embolization therapy for palliation of incurable bladder carcinoma

K. J. KloseGünther H. JacobiR. GüntherM. ThelenUdo Engelmann

subject

medicine.medical_specialtyUrinary bladderbusiness.industryUrologymedicine.medical_treatmenturologic and male genital diseasesmedicine.diseaseInternal iliac arteryfemale genital diseases and pregnancy complicationsSurgerymedicine.anatomical_structureUretermedicine.arteryOcclusionCarcinomaMedicineDysuriaRadiologyEmbolizationRenal arterymedicine.symptombusiness

description

Embolization therapy of the renal artery (N=10), hypogastric arteries (N=18) and ureter (N=24) was performed in 41 patients with incurable bladder carcinoma for palliation of gross hematuria and severe dysuria. Careful follow-up of the patients until death gave a mean survival time of 12.3 months after embolization; 6 patients are still alive. The results show that embolization therapy is justified for management of bleeding and dysuric complaints. Ureteral occlusion alone has almost no effect on hematuria. Combined embolization procedures yield better results than occlusion of the vessels or the ureter. Ureteral occlusion with a detachable balloon is superior to embolization with tissue adhesive.

https://doi.org/10.1007/bf00326723